Point72 Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.47M Buy
18,400
+13,800
+300% +$4.92M 0.01% 1531
2025
Q4
$1.51M Buy
+4,600
New +$1.46M ﹤0.01% 2647
2025
Q3
Sell
-266,800
Closed -$74.5M 2291
2025
Q2
$74.5M Buy
266,800
+29,100
+12% +$8.24M 0.15% 165
2025
Q1
$74.1M Buy
+237,700
New +$70.2M 0.17% 142
2024
Q4
Sell
-50,000
Closed -$16.1M 2057
2024
Q3
$16.1M Buy
+50,000
New +$16.4M 0.04% 485
2022
Q2
Sell
-200,000
Closed -$48.4M 1388
2022
Q1
$48.4M Buy
+200,000
New +$46M 0.19% 150
2018
Q4
Sell
-86,000
Closed -$17.8M 940
2018
Q3
$17.8M Buy
+86,000
New +$16.9M 0.07% 327

Other funds holding AMGN

Point72 Asset Management's AMGN Position: Q4 2023 in Review

Point72 Asset Management sold out of Amgen (AMGN) in Q4 2023, closing a stake of 268,743 shares — an estimated $72.2M sold.

Point72 Asset Management first reported a position in AMGN in Q2 2014 and held it in 5 quarters. The position peaked at $72.2M in Q3 2023. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Point72 Asset Management reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 268,743 Amgen shares in Q4 2023, an estimated $72.2M.
  • Point72 Asset Management first reported a position in Amgen in Q2 2014 and held it in 5 quarters.
  • Point72 Asset Management's Amgen position peaked at $72.2M in Q3 2023.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.